Filing Details
- Accession Number:
- 0001450324-16-000010
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-03-14 11:16:47
- Reporting Period:
- 2016-03-11
- Filing Date:
- 2016-03-14
- Accepted Time:
- 2016-03-14 11:16:47
- Original Submission Date:
- 2016-03-14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
946644 | Hemispherx Biopharma Inc | HEB | Biological Products, (No Disgnostic Substances) (2836) | 520845822 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1450324 | K. Thomas Equels | 4649 Ponce De Leon Blvd. #495 Coral Gables FL 33146 | Ceo,Pres,Exec Vice Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-11 | 30,000 | $0.16 | 1,444,548 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-03-11 | 10,000 | $0.16 | 1,454,548 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- To correct the amount of securities beneficially owned following the reported transaction.
- To correct the amount of securities beneficially owned following the reported transaction.